| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.00023 | 1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00015 | 1 |